Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapy (Englisch)
- Neue Suche nach: Geerts, H.
- Neue Suche nach: Finkel, L.
- Neue Suche nach: Carr, R.
- Neue Suche nach: Spiros, A.
- Neue Suche nach: Geerts, H.
- Neue Suche nach: Finkel, L.
- Neue Suche nach: Carr, R.
- Neue Suche nach: Spiros, A.
- Neue Suche nach: Jellinger, K.
- Neue Suche nach: Schmidt, R.
- Neue Suche nach: Windisch, M.
In:
Ageing and dementia; current and future concepts
;
203-216
;
2002
-
ISBN:
-
ISSN:
- Aufsatz (Konferenz) / Print
-
Titel:Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapy
-
Beteiligte:Geerts, H. ( Autor:in ) / Finkel, L. ( Autor:in ) / Carr, R. ( Autor:in ) / Spiros, A. ( Autor:in ) / Jellinger, K. / Schmidt, R. / Windisch, M.
-
Kongress:International symposium, Ageing and dementia; current and future concepts ; 1999 ; Graz, Austria
-
Erschienen in:JOURNAL OF NEURAL TRANSMISSION SUPPLEMENTUM ; 62 ; 203-216
-
Verlag:
- Neue Suche nach: Springer
-
Erscheinungsdatum:01.01.2002
-
Format / Umfang:14 pages
-
ISBN:
-
ISSN:
-
Medientyp:Aufsatz (Konferenz)
-
Format:Print
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis Konferenzband
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Vascular-ischemic dementia: an updateJellinger, K. A. et al. | 2002
- 25
-
Frequency of white matter lesions and silent lacunar infarctsvan Dijk, E. J. / Prins, N. D. / Vermeer, S. E. / Koudstaal, P. J. / Breteler, M. M. B. et al. | 2002
- 41
-
CT and MRI rating of white matter changesKapeller, P. / Schmidt, R. / Enzinger, C. / Ropele, S. / Fazekas, F. et al. | 2002
- 47
-
Risk factors and progression of small vessel disease-related cerebral abnormalitiesSchmidt, R. / Fazekas, F. / Enzinger, C. / Ropele, S. / Kapeller, P. / Schmidt, H. et al. | 2002
- 53
-
Microangiopathy-related cerebral damage and angiotensinogen gene: from epidemiology to biologySchmidt, H. / Fazekas, F. / Schmidt, R. et al. | 2002
- 61
-
Can small-vessel disease-related cerebral abnormalities be used as a surrogate marker for vascular dementia trials?Fazekas, F. / Ropele, S. / Schmidt, R. et al. | 2002
- 69
-
Reactive oxygen: its sources and significance in Alzheimer diseasePerry, G. / Nunomura, A. / Cash, A. D. / Taddeo, M. A. / Hirai, K. / Aliev, G. / Avila, J. / Wataya, T. / Shimohama, S. / Atwood, C. S. et al. | 2002
- 77
-
Dysregulation of neuronal differentiation and cell cycle control in Alzheimer's diseaseArendt, T. et al. | 2002
- 87
-
A broader horizon of Alzheimer pathogenesis: ALZAS - an early serum biomarker?Kienzl, E. / Jellinger, K. / Janetzky, B. / Steindl, H. / Bergmann, J. et al. | 2002
- 97
-
Is mild cognitive impairment bridging the gap between normal aging and Alzheimer's disease?Smith, G. et al. | 2002
- 105
-
Vienna Transdanube Aging "VITA": study design, recruitment strategies and level of participationFischer, P. / Jungwirth, S. / Krampla, W. / Weissgram, S. / Kirchmeyr, W. / Schreiber, W. / Huber, K. / Rainer, M. / Bauer, P. / Tragl, K. H. et al. | 2002
- 117
-
Conversion from preclinical to clinical stage of Alzheimer's disease as shown by decline of cognitive function in carriers of the Swedish APP-mutationAlmkvist, O. / Axelman, K. / Basun, H. / Wahlund, L.-O. / Lannfelt, L. et al. | 2002
- 127
-
The role of biological markers in the early and differential diagnosis of Alzheimer's diseaseKurz, A. / Riemenschneider, M. / Drzezga, A. / Lautenschlager, N. et al. | 2002
- 135
-
Measuring cognition in advanced Alzheimer's disease for clinical trialsSchmitt, F. A. / Cragar, D. / Ashford, J. W. / Reisberg, B. / Ferris, S. / Mobius, H.-J. / Stoffler, A. et al. | 2002
- 149
-
Current drugs and future hopes in the treatment of Alzheimer's diseaseWindisch, M. / Hutter-Paier, B. / Schreiner, E. et al. | 2002
- 165
-
Development of human antibody fragments directed towards synaptic acetylcholinesterase using a semi-synthetic phase display libraryFlores-Flores, C. / Nissim, A. / Shochat, S. / Soreq, H. et al. | 2002
- 181
-
Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer' diseaseGiacobini, E. et al. | 2002
- 189
-
Impact of muscarinic agonists for successful therapy of Alzheimer's diseaseFisher, A. / Brandeis, R. / Haring, R. / Bar-Ner, N. / Kliger-Spatz, M. / Natan, N. / Sonego, H. / Marcovitch, I. / Pittel, Z. et al. | 2002
- 203
-
Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapyGeerts, H. / Finkel, L. / Carr, R. / Spiros, A. et al. | 2002
- 217
-
Glutamate receptors as a target for Alzheimer's disease - are clinical results supporting the hope?Winblad, B. / Mobius, H. J. / Stoffler, A. et al. | 2002
- 227
-
Can estrogen play a significant role in the prevention of Alzheimer's disease?Kesslak, J. P. et al. | 2002
- 241
-
Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?Fahnestock, M. / Garzon, D. / Holsinger, R. M. D. / Michalski, B. et al. | 2002
- 253
-
Nerve growth factor and cholinergic CNS neurons studied in organotypic brain slicesHumpel, C. / Weis, C. et al. | 2002
- 265
-
Sustained improvement of cognition and global function in patients with moderately severe Alzheimer's disease: a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin®Ruether, E. / Alvarez, X. A. / Rainer, M. / Moessler, H. et al. | 2002
- 277
-
Improved global function and activities of daily living in patients with AD: a placebo-controlled clinical study with the neurotrophic agent Cerebrolysin®Muresanu, D. F. / Rainer, M. / Moessler, H. et al. | 2002
- 287
-
Genomics and dementia - new drug targets ahead?Mucke, H. A. M. et al. | 2002
- 293
-
Are beta-sheet breaker peptides dissolving the therapeutic problem of Alzheimer's disease?Permanne, B. / Adessi, C. / Fraga, S. / Frossard, M.-J. / Saborio, G. P. / Soto, C. et al. | 2002
- 303
-
Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease - a target for neuroprotective treatment strategies?Munch, G. / Deuther-Conrad, W. / Gasic-Milenkovic, J. et al. | 2002
- 309
-
Pharmacological targets to inhibit Alzheimer neurofibrillary degenerationIqbal, K. / del CAlonso, A. / El-Akkad, E. / Gong, C.-X. / Haque, N. / Khatoon, S. / Tsujio, I. / Grundke-Iqbal, I. et al. | 2002
- 321
-
Generation and brain delivery of anti-aggregating anti-bodies against beta-amyloid plaques using phage display technologySolomon, B. / Frenkel, D. et al. | 2002
- 327
-
Effects of Cerebrolysin™ on amyloid-beta deposition in a transgenic model of Alzheimer's diseaseRockenstein, E. / Mallory, M. / Mante, M. / Alford, M. / Windisch, M. / Moessler, H. / Masliah, E. et al. | 2002
- 337
-
Vitamin E binding protein Afamin protects neuronal cells in vitroHeiser, M. / Hutter-Paier, B. / Jerkovic, L. / Pfragner, R. / Windisch, M. / Becker-Andre, M. / Dieplinger, H. et al. | 2002
- 347
-
Recent developments in the pathology of Parkinson's diseaseJellinger, K. A. et al. | 2002